OpenBilldrug price receipt

NADAC week of 2026-10-14

CYCLOSPORINE MODIFIED 100 MG/ML

For 50 mL

Pharmacies pay

$101.84 filed

50 × $2.03685 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part B pays

$72.75 derived

50 × $1.455 per ML, Part B limit

Medicare's price is not your price.

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)


The spread

0.71× estimated

Medicare pays 29% less than pharmacies pay.

7 labelers share HCPCS J7502 on the CMS crosswalk, so its payment limit is an average across all their products billed under that code, not this NDC’s own price.

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

Cost-plus estimate

$122.12 estimated

$101.84 + $15.28 (15%) + $5.00 fee per fill = $122.12

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

CYCLOSPORINE MODIFIED 100 MG/ML is how the CMS NADAC file names this product. The FDA NDC Directory lists it as cyclosporine.

FDA gives its dosage form as solution and its route as oral.

The labeler, the company named on the label, is Teva Pharmaceuticals USA, Inc.

FDA’s Established Pharmacologic Class for it is Calcineurin Inhibitor Immunosuppressant.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00172-7313-20.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $101.84 for 50 mL (50 × $2.03685 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

The NDC

Other strengths, forms and brands

12 other products in the NADAC file share the FDA nonproprietary name cyclosporine with CYCLOSPORINE MODIFIED 100 MG/ML.

ProductPharmacies pay per unitMedicare per unit
CEQUA 0.09% SOLUTION
brand · solution/ drops
$10.38279 per EA filed
eff. 2026-09-23
$9.33517 per EA filed
Part D 2024 average
CYCLOSPORINE 0.05% EYE EMULSION
generic · emulsion
$0.90945 to $1.18033 per EA filed
eff. 2026-09-23
$4.32927 per EA filed
Part D 2024 average
CYCLOSPORINE 25 MG CAPSULE
generic · capsule, gelatin coated
$2.5957 per EA filed
eff. 2026-09-23
$0.576 per EA derived
Part B limit 2026 Q4
CYCLOSPORINE 100 MG CAPSULE
generic · capsule, gelatin coated
$7.50676 per EA filed
eff. 2026-09-23
$1.455 per EA derived
Part B limit 2026 Q4
CYCLOSPORINE MODIFIED 25 MG
generic · capsule, liquid filled
$0.31377 per EA filed
eff. 2026-09-23
$0.576 per EA derived
Part B limit 2026 Q4
CYCLOSPORINE MODIFIED 50 MG
generic · capsule, liquid filled
$0.76459 per EA filed
eff. 2026-09-23
$0.7275 to $1.152 per EA derived
Part B limit 2026 Q4
CYCLOSPORINE MODIFIED 100 MG
generic · capsule, liquid filled
$1.23348 per EA filed
eff. 2026-09-23
$1.455 per EA derived
Part B limit 2026 Q4
CYCLOSPORINE MODIFIED 100 MG/ML this page
generic · solution
$2.03685 per ML filed
eff. 2026-09-23
$1.455 per ML derived
Part B limit 2026 Q4
GENGRAF 25 MG CAPSULE
brand · capsule
$1.86549 per EA filed
eff. 2026-01-02
$1.14257 per EA filed
Part D 2024 average
NEORAL 25 MG GELATIN CAPSULE
brand · capsule, liquid filled
$2.94566 per EA filed
eff. 2026-07-08
$3.90784 per EA filed
Part D 2024 average
NEORAL 100 MG GELATIN CAPSULE
brand · capsule, liquid filled
$11.7731 per EA filed
eff. 2026-07-08
$3.90784 per EA filed
Part D 2024 average
RESTASIS 0.05% EYE EMULSION
brand · emulsion
$10.31247 to $10.31333 per EA filed
eff. 2026-09-23
$10.19841 per EA filed
Part D 2024 average
RESTASIS MULTIDOSE 0.05% EYE
brand · emulsion
$112.32159 per ML filed
eff. 2026-09-23
$111.93625 per ML filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-02, 2026-07-08, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)

What Medicare paid

Medicare Part B’s payment limit for HCPCS J7502, for 2026-10-01 to 2026-12-31, comes to $72.75 for 50 mL, or $1.455 per ML once converted to NADAC’s unit for this product.

Medicare Part B pays for this oral drug at a pharmacy only in specific circumstances CMS sets for this code; most prescriptions are paid by Part D.

The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.291 per 100 MG.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 50 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 50 mL in one package for this product’s NDC (“1 BOTTLE in 1 PACKAGE (0172-7313-20) / 50 mL in 1 BOTTLE”), so the card starts at one package: 50 ML. Change it to match your prescription.